Arvinas (ARVN) EBT Margin (2017 - 2026)

Arvinas (ARVN) recorded quarterly EBT Margin of 368.59% in Q1 2026, up 47.89% quarter-over-quarter from 707.37% in Q4 2025, and down 41260.0% on a YoY basis from N/an in Q1 2025.

Arvinas (ARVN) EBT Margin (2017 - 2026) Analysis & Trends

Arvinas' EBT Margin history runs 10 years deep, the most recent figure standing at 368.59% for Q1 2026.

  • In Q1 2026, EBT Margin fell 41260.0% year-over-year to 368.59%; the TTM figure through Mar 2026 stood at 247.2% (down 23643.0% YoY), while the FY2025 annual figure was 30.65%, up 4463.0% from the prior year.
  • EBT Margin was 368.59% for Q1 2026 at Arvinas, up from 707.37% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 355.45% in Q4 2023 to a low of 707.37% in Q4 2025.
  • Historically, EBT Margin has averaged 164.92% across 5 years, with a median of 184.04% in 2022.
  • The sharpest annual moves came in 2022 and 2025: EBT Margin soared 72490 bps in 2022, then sank 63051 bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 183.33% in 2022, then surged by 294 bps to 355.45% in 2023, then slumped by 122 bps to 76.86% in 2024, then slumped by 820 bps to 707.37% in 2025, then soared by 48 bps to 368.59% in 2026.
  • The last three EBT Margin figures came in at 368.59% (Q1 2026), 707.37% (Q4 2025), and 83.05% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - -368.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -368.59%
Dec 31, 2025 -707.37%
Sep 30, 2025 -83.05%
Jun 30, 2025 -274.55%
Mar 31, 2025 44.01%
Dec 31, 2024 -76.86%
Sep 30, 2024 -47.46%
Jun 30, 2024 -45.75%
Mar 31, 2024 -273.91%
Dec 31, 2023 355.45%
Sep 30, 2023 -184.68%
Jun 30, 2023 -120.37%
Mar 31, 2023 -249.85%
Dec 31, 2022 -183.33%
Sep 30, 2022 -184.04%
Jun 30, 2022 -189.64%
Mar 31, 2022 -213.58%
Dec 31, 2021 -138.86%
Sep 30, 2021 -503.23%
Jun 30, 2021 -914.55%